Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Long-Term Results Support Hypofractionated Whole-Breast Irradiation
Link ID 1604
Title Long-Term Results Support Hypofractionated Whole-Breast Irradiation
Url http://www.medscape.com/viewarticle/567489?src=rss
Description Researchers are encouraging broader use of hypofractionated irradiation in early breast cancer. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Dec 15, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Physician Influence Strongest Determinant of Colorectal Screening
  Patients who discussed colorectal cancer screening with a physician were significantly more likely to undergo screening, whereas those who reported barriers to screening were less likely to undergoing any of the available tests. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Markers Predict Response Rate and Prognosis After Temozolomide Treatment
  Researchers have identified a genetic marker that appears to predict chemosensitivity to temozolomide treatment and prognosis in gliomatosis cerebri brain tumors. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. Video Highlights From the American Society of Clinical Oncology 44th Annual Meeting
  Research that will affect clinical practice includes a study showing that zoledronic acid reduces relapse in early breast cancer and KRAS mutations predict which patients will respond to cetuximab. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. National Comprehensive Cancer Network (NCCN) Prostate Cancer Guideline, Version 1.2008
  The National Comprehensive Cancer Network presents its current clincial guidelines for the treatment of prostate cancer.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. Treatment With VEGF Inhibitors May Cause Renal Thrombotic Microangiopathy
  VEGF inhibitors, such as bevacizumab, may cause glomerular disease that is characteristic of thrombotic microangiopathy. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS